GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » EV-to-FCF

Instituto Rosenbusch (BUE:ROSE) EV-to-FCF : 8.70 (As of May. 28, 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Instituto Rosenbusch's Enterprise Value is ARS5,509 Mil. Instituto Rosenbusch's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ARS633 Mil. Therefore, Instituto Rosenbusch's EV-to-FCF for today is 8.70.

The historical rank and industry rank for Instituto Rosenbusch's EV-to-FCF or its related term are showing as below:

BUE:ROSE' s EV-to-FCF Range Over the Past 10 Years
Min: -172.09   Med: 7   Max: 4193.46
Current: 55.56

During the past 13 years, the highest EV-to-FCF of Instituto Rosenbusch was 4193.46. The lowest was -172.09. And the median was 7.00.

BUE:ROSE's EV-to-FCF is ranked worse than
78.41% of 528 companies
in the Drug Manufacturers industry
Industry Median: 24.695 vs BUE:ROSE: 55.56

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), Instituto Rosenbusch's stock price is ARS114.25. Instituto Rosenbusch's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ARS22.032. Therefore, Instituto Rosenbusch's PE Ratio for today is 5.19.


Instituto Rosenbusch EV-to-FCF Historical Data

The historical data trend for Instituto Rosenbusch's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instituto Rosenbusch EV-to-FCF Chart

Instituto Rosenbusch Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.57 13.64 14.26 19.92 35.73

Instituto Rosenbusch Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -90.43 -46.34 31.11 35.73 -

Competitive Comparison of Instituto Rosenbusch's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instituto Rosenbusch's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's EV-to-FCF falls into.



Instituto Rosenbusch EV-to-FCF Calculation

Instituto Rosenbusch's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5508.912/633.468
=8.70

Instituto Rosenbusch's current Enterprise Value is ARS5,509 Mil.
Instituto Rosenbusch's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS633 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instituto Rosenbusch  (BUE:ROSE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Instituto Rosenbusch's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=114.25/22.032
=5.19

Instituto Rosenbusch's share price for today is ARS114.25.
Instituto Rosenbusch's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS22.032.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Instituto Rosenbusch EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Instituto Rosenbusch (BUE:ROSE) Business Description

Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.